These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 116549)

  • 1. Complement in tears from normal humans.
    Yamamoto GK; Allansmith MR
    Am J Ophthalmol; 1979 Oct; 88(4):758-63. PubMed ID: 116549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic complement in tears.
    Mondino BJ; Zaidman GW
    Ophthalmic Res; 1983; 15(4):208-11. PubMed ID: 6634056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of rat complement activities by infusion of anti-H antibodies.
    Veerhuis R; van Es LA; Daha MR
    Immunobiology; 1985 Sep; 170(3):133-45. PubMed ID: 2932382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate and classical pathway components of complement in the normal cornea.
    Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
    Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the alternative pathway of complement in the newborn infant.
    Adamkin D; Stitzel A; Urmson J; Farnett ML; Post E; Spitzer R
    J Pediatr; 1978 Oct; 93(4):604-8. PubMed ID: 702236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel assay for serum complement activity: C42 generation assay.
    Kobayashi E; Kitano E; Kitamura H
    Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between the haemolytic activities of the human complement system and complement components.
    Takada A; Imamura Y; Takada Y
    Clin Exp Immunol; 1979 Feb; 35(2):324-8. PubMed ID: 436337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of complement activity and components C1, C4, C2, and C3 in complement response to bacterial challenge in malnourished rats.
    Sakamoto M; Ishii S; Nishioka K; Shimada K
    Infect Immun; 1981 May; 32(2):553-6. PubMed ID: 7251136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians.
    Bellavia D; Fradà G; Di Franco P; Feo S; Franceschi C; Sansoni P; Brai M
    J Gerontol A Biol Sci Med Sci; 1999 Apr; 54(4):B150-3. PubMed ID: 10219002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo changes in human complement caused by silage.
    Olenchock SA; May JJ; Pratt DS; Lewis DM; Mull JC; Stallones L
    Environ Health Perspect; 1986 Apr; 66():91-6. PubMed ID: 3709488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 16. The classical and alternate pathways of complement in oral contraceptive users.
    Delâge JM; Lehner-Netsch G; Brisson J
    Contraception; 1987 Dec; 36(6):627-32. PubMed ID: 3446439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement proteins and C3 anaphylatoxin in the tears of patients with conjunctivitis.
    Ballow M; Donshik PC; Mendelson L
    J Allergy Clin Immunol; 1985 Sep; 76(3):473-6. PubMed ID: 3875643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
    Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
    J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement consumption in acute disseminated intravascular coagulation without antecedent immunopathology.
    Branson HE; Wyatt LL; Schmer G
    Am J Clin Pathol; 1976 Dec; 66(6):967-75. PubMed ID: 136895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.